Hedge Fund - Enavate Sciences
Get Email AlertsJames Boylan Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Enavate Sciences |
| Manager | James Boylan |
| Portfolio Value | $132,721,569 |
| Change This QTR | +0.95% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | IMNM | 4,768,583 | $32,092,564 | +38% | 24.18% | ||
| 2. | Zenas Biopharma Inc | 3,761,359 | $29,714,736 | 22.39% | |||
| 3. | Sionna Therapeutics Inc | 2,478,030 | $25,920,194 | NEW | 19.53% | ||
| 4. | Camp4 Therapeutics Corp | 3,785,802 | $15,143,208 | 11.41% | |||
| 5. | Upstream Bio Inc | 2,459,703 | $15,053,382 | 11.34% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2025-02-18 | ||||
| 2024-10-22 | ||||
| 2024-09-23 |
